to screen prioritized FDA-approved drugs against SARS-CoV-2 in vitro
- Funded by Gates Foundation
- Total publications:3 publications
Grant number: INV-006099
Grant search
Key facts
Disease
COVID-19start year
2020Known Financial Commitments (USD)
$717,958Funder
Gates FoundationPrincipal Investigator
N/A
Research Location
United States of AmericaLead Research Institution
University of Maryland, BaltimoreResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
N/A
Publicationslinked via Europe PMC
Last Updated:41 minutes ago
View all publications at Europe PMC